🇺🇸 FDA
Pipeline program

midodrine hydrochloride (ProAmatine®)

SPD 426-403

Approved small_molecule terminated

Quick answer

midodrine hydrochloride (ProAmatine®) for Hypotension, Orthostatic is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hypotension, Orthostatic
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials